Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to to assess the feasibility and safety of left atrial appendage (LAA) occlusion with the WATCHMAN FLX™ device using a standardized intra-procedural intracardiac echocardiography (ICE) protocol under moderate sedation for procedural guidance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05136417
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date January 4, 2022
Completion date December 15, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03987945 - Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai
Completed NCT05632445 - Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA) Phase 4
Terminated NCT00841529 - Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage Phase 2
Recruiting NCT05554822 - Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study Phase 3
Not yet recruiting NCT04897204 - Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation N/A
Recruiting NCT04524780 - Use of Intracardiac Echocardiography or Left Atrial Appendage Radiography to Guide Implantation of a Left Atrial Appendage Occlusion Device. N/A
Recruiting NCT04524741 - Use of Intracardiac Echocardiography or Left Atrial Appendage Radiography to Guide Implantation of a Left Atrial Appendage Occlusion Device N/A
Withdrawn NCT05399342 - Left Atrial Appendage Occlusion Study III Extended Follow Up
Recruiting NCT05671276 - Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion Phase 4
Recruiting NCT06060912 - LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs N/A
Recruiting NCT04502017 - Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion Phase 4